Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
284.68
+4.49 (1.60%)
At close: Mar 4, 2026, 4:00 PM EST
284.68
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:10 PM EST

Bio-Rad Laboratories Revenue

In the year 2025, Bio-Rad Laboratories had annual revenue of $2.58B with 0.65% growth. Bio-Rad Laboratories had revenue of $693.20M in the quarter ending December 31, 2025, with 3.85% growth.

Revenue (ttm)
$2.58B
Revenue Growth
+0.65%
P/S Ratio
2.94
Revenue / Employee
$346,738
Employees
7,450
Market Cap
7.68B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.58B16.70M0.65%
Dec 31, 20242.57B-104.70M-3.92%
Dec 31, 20232.67B-131.00M-4.67%
Dec 31, 20222.80B-120.35M-4.12%
Dec 31, 20212.92B376.92M14.81%
Dec 31, 20202.55B233.97M10.12%
Dec 31, 20192.31B22.24M0.97%
Dec 31, 20182.29B129.26M5.98%
Dec 31, 20172.16B91.98M4.45%
Dec 31, 20162.07B48.73M2.41%
Dec 31, 20152.02B-155.60M-7.15%
Dec 31, 20142.18B42.35M1.99%
Dec 31, 20132.13B63.46M3.07%
Dec 31, 20122.07B-4.29M-0.21%
Dec 31, 20112.07B146.41M7.60%
Dec 31, 20101.93B142.87M8.01%
Dec 31, 20091.78B19.88M1.13%
Dec 31, 20081.76B303.31M20.76%
Dec 31, 20071.46B187.12M14.69%
Dec 31, 20061.27B92.95M7.87%
Dec 31, 20051.18B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Smith & Nephew6.16B
Bruker3.44B
Globus Medical2.94B
Insulet2.71B
Bio-Rad Laboratories2.58B
Masimo1.53B
Penumbra1.40B
LivaNova1.39B
Revenue Rankings